Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: Biomarkers of Clopidogrel Resistance for Predicting Ischemic Recurrence After Cerebral Artery Stenting

View source ↗

Summary

A planned clinical study from Nanjing First Hospital and Nanjing Medical University aims to identify biomarkers of clopidogrel resistance to predict recurrent i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Ischemic Stroke | Status: NOT_YET_RECRUITING